Mesenchymal Stem Cells from Cervix and Age: New Insights into CIN Regression Rate

Table 2

Immunophenotype of MSCs derived from the cervixes of young (yC-MSCs) and old (oC-MSCs) patients.

	yC-MSCs	oC-MSCs
HLA-DR	−	−
CD14	−	−
CD19	−	−
CD34	−	−
CD45	−	−
CD73	+	+
CD90	+	+
CD105	+	+
CD9	−	−

Positive immunolabelling (+) was defined as a level of fluorescence > 90% of the corresponding isotype-matched control antibodies. Percentages < 2% were considered negative (−). No differences were noted between the two subgroups.